AF
TNDM icon

Amalgamated Financial’s Tandem Diabetes Care TNDM Stock Holding History

Amalgamated Financial’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5.45M Buy
+46,865
New +$5.47M 0.04% 418

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Amalgamated Financial's TNDM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Tandem Diabetes Care (TNDM) in Q1 2022: 46,865 shares worth $5.45M. The stake represents 0.04% of the portfolio and ranks #418 among its holdings.

379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Amalgamated Financial held 46,865 shares of Tandem Diabetes Care worth $5.45M as of Q1 2022.
  • Tandem Diabetes Care was a new Amalgamated Financial position in Q1 2022.
  • Tandem Diabetes Care made up 0.04% of Amalgamated Financial's portfolio in Q1 2022, its #418 holding.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.